# Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome

> **NCT02080624** · PHASE2 · COMPLETED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 23 (actual)

## Conditions studied

- Sturge- Weber Syndrome

## Interventions

- **DRUG:** Drug: Topical Rapamycin

## Key facts

- **NCT ID:** NCT02080624
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-09
- **Final completion:** 2012-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2014-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02080624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02080624, "Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02080624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*